BioLife Solutions (BLFS) Competitors $27.32 -0.41 (-1.48%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$27.31 -0.01 (-0.04%) As of 10/17/2025 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. BLCO, GKOS, TMDX, SLNO, NVST, LIVN, WRBY, INSP, EYE, and LQDAShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), National Vision (EYE), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Its Competitors Bausch + Lomb Glaukos TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems National Vision Liquidia Technologies Bausch + Lomb (NYSE:BLCO) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Do insiders & institutionals have more ownership in BLCO or BLFS? 11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 0.8% of Bausch + Lomb shares are held by company insiders. Comparatively, 2.2% of BioLife Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to BLCO or BLFS? In the previous week, BioLife Solutions had 10 more articles in the media than Bausch + Lomb. MarketBeat recorded 11 mentions for BioLife Solutions and 1 mentions for Bausch + Lomb. BioLife Solutions' average media sentiment score of 0.30 beat Bausch + Lomb's score of 0.30 indicating that BioLife Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch + Lomb 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioLife Solutions 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, BLCO or BLFS? Bausch + Lomb has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500. Do analysts rate BLCO or BLFS? Bausch + Lomb presently has a consensus price target of $15.70, suggesting a potential upside of 4.77%. BioLife Solutions has a consensus price target of $31.29, suggesting a potential upside of 14.52%. Given BioLife Solutions' stronger consensus rating and higher possible upside, analysts plainly believe BioLife Solutions is more favorable than Bausch + Lomb.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch + Lomb 2 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08BioLife Solutions 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has higher valuation & earnings, BLCO or BLFS? BioLife Solutions has lower revenue, but higher earnings than Bausch + Lomb. BioLife Solutions is trading at a lower price-to-earnings ratio than Bausch + Lomb, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch + Lomb$4.79B1.11-$317M-$0.78-19.21BioLife Solutions$93.47M14.00-$20.18M-$0.12-227.67 Is BLCO or BLFS more profitable? BioLife Solutions has a net margin of -5.39% compared to Bausch + Lomb's net margin of -5.58%. Bausch + Lomb's return on equity of 2.33% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Bausch + Lomb-5.58% 2.33% 1.12% BioLife Solutions -5.39%0.16%0.14% SummaryBioLife Solutions beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.33B$10.71B$6.09B$10.49BDividend YieldN/A1.89%5.73%4.80%P/E Ratio-227.6519.6784.7527.11Price / Sales14.0031.15519.29179.59Price / Cash226.3525.0337.1661.22Price / Book3.633.4112.246.52Net Income-$20.18M$210.63M$3.33B$276.84M7 Day Performance1.94%0.03%1.19%1.95%1 Month Performance3.96%-1.38%6.18%2.21%1 Year Performance15.62%-9.70%59.89%34.06% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.4146 of 5 stars$27.32-1.5%$31.29+14.5%+18.1%$1.33B$93.47M-227.65440Positive NewsInsider TradeBLCOBausch + Lomb1.6369 of 5 stars$14.87+3.8%$15.70+5.6%-28.4%$5.07B$4.79B-19.0613,500GKOSGlaukos4.4096 of 5 stars$83.11+0.7%$116.92+40.7%-32.2%$4.73B$383.48M-50.37780TMDXTransMedics Group3.381 of 5 stars$111.71+4.1%$127.18+13.8%-7.5%$3.66B$441.54M57.88210Analyst ForecastSLNOSoleno Therapeutics4.1441 of 5 stars$64.27+0.8%$115.92+80.4%+22.4%$3.39BN/A-15.5230NVSTEnvista4.1569 of 5 stars$19.23+0.9%$21.08+9.6%+9.4%$3.17B$2.51B60.1012,300News CoverageAnalyst RevisionLIVNLivaNova2.8907 of 5 stars$51.78+2.2%$59.71+15.3%+1.0%$2.77B$1.25B-13.312,900WRBYWarby Parker2.5907 of 5 stars$22.17-0.4%$24.75+11.7%+34.4%$2.34B$821.35M-316.613,780Positive NewsINSPInspire Medical Systems4.8923 of 5 stars$77.57+3.2%$150.50+94.0%-60.4%$2.22B$802.80M44.841,246News CoverageAnalyst ForecastAnalyst RevisionEYENational Vision2.6506 of 5 stars$26.37+3.2%$24.73-6.2%+157.1%$2.02B$1.82B-146.5013,411Positive NewsAnalyst UpgradeLQDALiquidia Technologies3.5721 of 5 stars$23.77+2.5%$32.38+36.2%+96.2%$2.00B$14M-13.9850Trending NewsInsider TradeGap Down Related Companies and Tools Related Companies Bausch + Lomb Competitors Glaukos Competitors TransMedics Group Competitors Soleno Therapeutics Competitors Envista Competitors LivaNova Competitors Warby Parker Competitors Inspire Medical Systems Competitors National Vision Competitors Liquidia Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNvidia CEO’s Regret: ‘I Wish I Gave [Elon] More’…Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
